Your session is about to expire
← Back to Search
Basimglurant for Tuberous Sclerosis
Study Summary
This trial will test whether basimglurant is an effective seizure control medication for children and adolescents with Tuberous Sclerosis Complex.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing to take pregnancy tests if I can have children.I am between 5 and 30 years old.I have a neurological condition that is not tuberous sclerosis complex.My seizures do not respond to treatment.I am currently taking medication for epilepsy.I weigh less than 15kg.I do not have any unstable health conditions.I am willing to fill out surveys about my health condition.My epilepsy treatment has been consistent without changes.I have been diagnosed with Tuberous Sclerosis Complex (TSC).
- Group 1: Arm A (Basimglurant to Placebo)
- Group 2: Arm B (Placebo to Basimglurant)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
At how many locations is this trial being conducted?
"Presently, this trial is being conducted in 25 hospitals, with locations in large cities such as Roseville, Houston and Baltimore. If you are considering participating in this study, know that it might be helpful to select a site nearer to your home to reduce travel costs."
Will this experiment be testing subjects who are over 25 years old?
"This clinical trial's requirements for patient participation state that prospective enrollees must be between 5 and 30 years old."
How many people can participate in this experiment at most?
"That is correct, the online clinicaltrials.gov database shows that this research is looking for volunteers right now. The listing went up on March 3rd, 2021 and was updated October 13th, 2022. So far, 54 people have signed up at 25 different hospitals or clinics."
Has Arm A (Basimglurant to Placebo) received FDA clearance?
"While Phase 2 trials are not as reliable in terms of efficacy, the data collected suggests that Arm A is safe. Therefore, it was given a score of 2."
Are there any current vacancies for participants in this trial?
"This clinical trial, which was originally posted on March 3rd 2021 according to information from clinicaltrials.gov, is currently looking for patients."
Share this study with friends
Copy Link
Messenger